- Home
- DARE vs RYOJ Comparison
DARE vs RYOJ Comparison
Compare DARE & RYOJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DARE
- RYOJ
- Stock Information
- Founded
- DARE 2015
- RYOJ 2015
- Country
- DARE United States
- RYOJ Japan
- Employees
- DARE N/A
- RYOJ N/A
- Industry
- DARE Biotechnology: Pharmaceutical Preparations
- RYOJ Professional Services
- Sector
- DARE Health Care
- RYOJ Consumer Discretionary
- Exchange
- DARE Nasdaq
- RYOJ Nasdaq
- Market Cap
- DARE 28.0M
- RYOJ 24.2M
- IPO Year
- DARE N/A
- RYOJ 2025
- Fundamental
- Price
- DARE $2.25
- RYOJ $2.02
- Analyst Decision
- DARE Strong Buy
- RYOJ
- Analyst Count
- DARE 2
- RYOJ 0
- Target Price
- DARE $10.00
- RYOJ N/A
- AVG Volume (30 Days)
- DARE 123.3K
- RYOJ 168.0K
- Earning Date
- DARE 11-13-2025
- RYOJ 01-01-0001
- Dividend Yield
- DARE N/A
- RYOJ N/A
- EPS Growth
- DARE N/A
- RYOJ 72.91
- EPS
- DARE N/A
- RYOJ 0.13
- Revenue
- DARE N/A
- RYOJ $11,576,848.00
- Revenue This Year
- DARE $6,864.02
- RYOJ N/A
- Revenue Next Year
- DARE $4,922.46
- RYOJ N/A
- P/E Ratio
- DARE N/A
- RYOJ $17.06
- Revenue Growth
- DARE N/A
- RYOJ 5.60
- 52 Week Low
- DARE $1.83
- RYOJ $1.81
- 52 Week High
- DARE $9.19
- RYOJ $3.75
- Technical
- Relative Strength Index (RSI)
- DARE 61.86
- RYOJ N/A
- Support Level
- DARE $2.11
- RYOJ N/A
- Resistance Level
- DARE $2.28
- RYOJ N/A
- Average True Range (ATR)
- DARE 0.07
- RYOJ 0.00
- MACD
- DARE 0.02
- RYOJ 0.00
- Stochastic Oscillator
- DARE 91.96
- RYOJ 0.00
About DARE Dare Bioscience Inc.
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.
About RYOJ rYojbaba Co. Ltd. Common Shares
rYojbaba Co Ltd is engaged in improving and restoring physical and mental health diminished by work-related stress through consulting and health services. The company provides consulting services to labor unions and companies wishing to build constructive relationships with labor unions and health services to osteopathic clinics and osteopathic beauty salons to alleviate physical ailments created by work-related stress.